Now in the twenty-first century, classic psychedelics have regained attention and are finally receiving the same gold standard study’s required by science for any medicine and the results are amazing. Several promising studies have been completed and are not only validating the earlier studies but are blowing their synthetic counterparts out of the water. The primary studies we will look at here involve Psilocybin but I plan to cover even more promising studies for MDMA and Iboga in the coming articles.